The influence of body mass index on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in women with early-stage breast cancer

PURPOSE: To investigate the influence of body mass index (BMI) on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in early breast cancer patients. METHODS: Early-stage breast cancer patients who received (neo)adjuvant weekly paclitaxel 80 mg/m(2) chemotherapy were inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Lishi, Soesan, Marcel, van Balen, Dorieke E. M., Beijnen, Jos H., Huitema, Alwin D. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464742/
https://www.ncbi.nlm.nih.gov/pubmed/35974240
http://dx.doi.org/10.1007/s10549-022-06681-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464742/
https://www.ncbi.nlm.nih.gov/pubmed/35974240
http://dx.doi.org/10.1007/s10549-022-06681-6

Ejemplares similares